Medindia » Medication Manual » Azilsartan Medoxomil and Chlorthalidone

Azilsartan Medoxomil and Chlorthalidone

Updated on : October - 2012
Latest prescription information about Azilsartan Medoxomil and Chlorthalidone. Learn how to pronounce the drug’s name, its indications, dosage, how to take, when to take, when not to take, side effects, special precautions, its storage instructions and warnings if any when taken during pregnancy. Also listed are the International and Indian trade name(s) of the drug and its price list.
Email Email print Print Save this page Save Syndicate Syndicate
Generic Name : Azilsartan Medoxomil and Chlorthalidone
Therapeutic Classification : Anti- Hypertensives And ACE Inhibitors
ICD Code : Y52.4
Trade Name(s): 
International- Edarbyclor.
Why it is prescribed (Indications) : 
This combination medication contains an angiotensin II receptor blocker and the diuretic chlorthalidone, prescribed for the treatment of hypertension. 
When it is not to be taken (Contraindications):  Contraindicated in patients with kidney problems and diabetes.

Pregnancy Category :

A B C D X
Category D : There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Dosage & When it is to be taken : 
PO- The recommended starting dose is 40/12.5 mg once daily.
How it should be taken : 
It comes as a tablet to take by mouth, with or without food.
Warnings and Precautions : 
* Caution should be exercised in patients with liver or kidney problems, stroke, heart disease, severe vomiting or diarrhea, gout, who are taking other medications, any allergy, during pregnancy and breastfeeding.
* It may cause dizziness, do not drive a car or operate machinery and lie down while taking this medication.
* Patient may develop with electrolyte problems; if it is so consult with your doctor.
Side Effects : 
Dizziness and fatigue.
Other Precautions : 
* Avoid excess dosage.
Storage Conditions : 
Store it at room temperature (20°C to 25°C).
♦ Safety Labeling Changes Approved By FDA


Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.

Browse the Drugs alphabetically

Reference  

  • Food and Drug Administration (FDA)
  • National Institutes of Health (NIH)
  • PubMed
  • CIMS
  • Indian Pharma Reference Guide 2012
Drugs Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z